WASHINGTON - The Food and Drug Administration is hosting a public meeting Tuesday that is a key step in deciding whether to open COVID-19 vaccinations to kids aged 5 to 11.The FDA is asking a panel of outside vaccine experts to review its analysis and vote on whether to recommend the Pfizer-BioNTech COVID-19 vaccine for the nation’s roughly 28 million children in that age range before the agency makes a decision.
If the FDA authorizes the shots, the U.S. Centers for Disease Control and Prevention will make additional recommendations on who should receive them the first week of November.
Read more on fox29.com